Resolving Gene Editing Technology's Ethical and Regulatory Challenges
By Vidya Narayanaswami, PhD, Dr. Stephen F. Amato -
Published 13 December 2017
This article provides an overview of biomedical applications of gene editing technology, addresses ethical and regulatory challenges associated with its implementation for therapeutic development, and proposes approaches for overcoming these challenges.
Categories: Features, FDA, Biologics and biotechnology, Ethics
Tags: Gene Editing, Gene Therapy, CRISPR, Cas9